Wearable developer Empatica aims to develop new digital biomarkers

Empatica Chief Medical Officer Dr. Marisa Cruz discusses advances in wearable technology and how new digital biomarkers could advance medtech.

Empatica Chief Medical Officer Dr. Marisa Cruz [Photo courtesy of Empatica]

Dr. Marisa Cruz envisions a future where unobtrusive wearable devices with advanced sensors will continuously measure and record actionable biodata without patients having to lift a finger.

Cruz is an endocrinologist and internist who serves as chief medical officer at Empatica, which develops wearable devices for monitoring patient physiology with the ultimate goal of improving clinical outcomes.

In 2011, Empatica spun out of an MIT lab focused on wearable sensors for continuous, passive patient monitoring. That technology is made possible by ever-shrinking sensors and batteries, gains in effective computing, and materials and manufacturing methods that result in comfortable and intuitive…

Read more
  • 0

Pear Therapeutics inks multiple agreements to expand digital therapeutic platform

Pear Therapeutics announced today that it entered into multiple agreements to bolster its prescription digital therapeutics (PDT) platform.

Boston-based Pear Therapeutics’ agreements are set to add to its library of digital biomarkers, machine learning algorithms, sensor-based technologies and digital therapeutics, according to a news release.

Get the full story at our sister site, Drug Delivery Business News.

Read more
  • 0